Benzodiazepine effect on information processing in generalized anxiety disorder

Area of Science:

• Psychopharmacology
• Neuroscience
• Clinical Psychology

Background:

• Generalized anxiety disorder (GAD) is characterized by heightened physiological arousal.
• Electrodermal activity (EDA) is a key psychophysiological indicator of arousal.
• Current treatments for GAD vary in efficacy and side effect profiles.

Purpose of the Study:

• To compare the effects of bromazepam, diazepam, and placebo on electrodermal activity in anxious patients.
• To investigate psychophysiological responses to sensory stimuli under different treatment conditions.
• To explore the utility of a functional-realistic-instrumental paradigm in anxiety research.

Main Methods:

• A double-blind, randomized trial involving 45 adult patients with generalized anxiety disorder.
• Administration of bromazepam, diazepam, or placebo over 14 days.
• Monitoring of electrodermal activity (skin conductance) in response to non-signal, simple, and complex sensory stimuli at multiple time points.

Main Results:

• Bromazepam treatment led to a significant decrease in skin conductance during visual, auditory, and tactile stimuli.
• Patients receiving diazepam or placebo did not exhibit significant changes in skin conductance.
• These findings suggest differential effects of benzodiazepines on psychophysiological arousal in GAD.

Conclusions:

• Bromazepam demonstrates potential as a treatment for reducing anxiety-related hyperarousal.
• Electrodermal activity serves as a sensitive measure for assessing treatment effects in GAD.
• A functional-realistic-instrumental approach may offer a more comprehensive understanding of anxiety than attentional-arousal models.